Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy
Windtree Therapeutics (NASDAQ:WINT) has secured up to $520 million in new funding to expand its BNB cryptocurrency treasury strategy. The funding consists of a $500 million equity line of credit (ELOC) and a $20 million stock purchase agreement with Build and Build Corp.
The company plans to allocate 99% of the proceeds from both agreements to acquiring BNB cryptocurrency. The ELOC implementation is contingent on stockholder approval to increase authorized shares of common stock. This strategic move represents Windtree's effort to diversify its treasury assets through blockchain-based digital currencies.
Windtree Therapeutics (NASDAQ:WINT) ha ottenuto fino a 520 milioni di dollari di nuovi finanziamenti per espandere la sua strategia di tesoreria in criptovaluta BNB. Il finanziamento comprende una linea di credito azionaria (ELOC) da 500 milioni di dollari e un accordo di acquisto azionario da 20 milioni di dollari con Build and Build Corp.
L'azienda prevede di destinare il 99% dei proventi derivanti da entrambi gli accordi all'acquisto di criptovaluta BNB. L'attuazione della ELOC dipende dall'approvazione degli azionisti per aumentare le azioni ordinarie autorizzate. Questa mossa strategica rappresenta l'impegno di Windtree nel diversificare i propri asset di tesoreria attraverso valute digitali basate su blockchain.
Windtree Therapeutics (NASDAQ:WINT) ha asegurado hasta 520 millones de dólares en nuevos fondos para expandir su estrategia de tesorería en criptomoneda BNB. La financiación consiste en una línea de crédito de capital (ELOC) de 500 millones de dólares y un acuerdo de compra de acciones por 20 millones de dólares con Build and Build Corp.
La compañía planea destinar el 99% de los ingresos de ambos acuerdos a la adquisición de la criptomoneda BNB. La implementación de la ELOC está condicionada a la aprobación de los accionistas para aumentar las acciones comunes autorizadas. Este movimiento estratégico representa el esfuerzo de Windtree por diversificar sus activos de tesorería mediante monedas digitales basadas en blockchain.
Windtree Therapeutics (NASDAQ:WINT)는 BNB 암호화폐 재무 전략을 확장하기 위해 최대 5억 2천만 달러의 신규 자금을 확보했습니다. 이 자금은 5억 달러의 주식 신용 한도(ELOC)와 Build and Build Corp와의 2천만 달러 주식 매입 계약으로 구성됩니다.
회사는 두 계약에서 발생하는 수익의 99%를 BNB 암호화폐 매입에 할당할 계획입니다. ELOC 시행은 보통주 승인 주식 수 증가에 대한 주주 승인에 따라 달라집니다. 이 전략적 조치는 Windtree가 블록체인 기반 디지털 화폐를 통해 재무 자산을 다각화하려는 노력의 일환입니다.
Windtree Therapeutics (NASDAQ:WINT) a obtenu jusqu'à 520 millions de dollars de nouveaux financements pour étendre sa stratégie de trésorerie en cryptomonnaie BNB. Ce financement comprend une ligne de crédit en actions (ELOC) de 500 millions de dollars et un accord d'achat d'actions de 20 millions de dollars avec Build and Build Corp.
La société prévoit d'allouer 99 % des recettes des deux accords à l'acquisition de la cryptomonnaie BNB. La mise en œuvre de l'ELOC dépend de l'approbation des actionnaires pour augmenter le nombre d'actions ordinaires autorisées. Cette démarche stratégique reflète l'effort de Windtree pour diversifier ses actifs de trésorerie via des monnaies numériques basées sur la blockchain.
Windtree Therapeutics (NASDAQ:WINT) hat bis zu 520 Millionen US-Dollar an neuen Finanzmitteln erhalten, um seine BNB-Kryptowährungs-Treasury-Strategie auszubauen. Die Finanzierung besteht aus einer 500-Millionen-Dollar-Aktienkreditlinie (ELOC) und einer 20-Millionen-Dollar-Aktienkaufvereinbarung mit Build and Build Corp.
Das Unternehmen plant, 99 % der Erlöse aus beiden Vereinbarungen für den Erwerb der BNB-Kryptowährung zu verwenden. Die Umsetzung der ELOC hängt von der Zustimmung der Aktionäre zur Erhöhung der genehmigten Stammaktien ab. Dieser strategische Schritt stellt Windtrees Bemühungen dar, seine Treasury-Vermögenswerte durch blockchain-basierte digitale Währungen zu diversifizieren.
- Secured up to $520 million in new funding through ELOC and stock purchase agreement
- Strategic diversification into cryptocurrency treasury management
- Partnership with Build and Build Corp for additional funding support
- ELOC implementation requires stockholder approval and share dilution
- 99% allocation to cryptocurrency represents significant concentration risk
- Substantial pivot from core biotechnology business to crypto investments
Insights
Windtree's pivot to a BNB-focused treasury represents a radical departure from biotech operations toward speculative cryptocurrency exposure.
Windtree Therapeutics, traditionally a biotechnology company, has unveiled a dramatic strategic shift by securing up to
What's particularly notable is that
The announcement lacks several critical elements that investors would typically expect:
- No mention of how this cryptocurrency strategy relates to Windtree's historical focus on developing drug candidates for respiratory and cardiovascular diseases
- No disclosure of any remaining clinical programs or drug development activities
- No explanation of why BNB specifically was selected over other cryptocurrencies
- No discussion of risk management strategies for cryptocurrency volatility
Implementation of the ELOC requires stockholder approval to increase authorized shares, suggesting significant dilution potential. The company describes this as "diversifying its portfolio through strategic initiatives," but effectively appears to be transforming from a biotechnology company into a cryptocurrency investment vehicle.
The statement from Build and Build Corp's director describing this as a "forward-thinking approach to value creation" lacks substantive explanation of how cryptocurrency holdings create sustainable value in a pharmaceutical context. This transaction represents an unconventional and high-risk strategic redirection that fundamentally alters Windtree's business model.
Up to
Ninety Nine Percent of the proceeds from both issuances to be used to buy BNB
WARRINGTON, Pa., July 24, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company diversifying its portfolio through strategic initiatives, today announced it has entered into a Common Stock Purchase Agreement for up to
"We are excited to incorporate these new facilities to enable our future BNB acquisitions as part of our BNB treasury strategy," stated Jed Latkin, CEO of Windtree. "Pending stockholder approval, the opportunity to secure additional funds for purchasing more BNB cryptocurrency is essential to our strategy."
Establishing the ELOC reflects Windtree’s strategy to diversify its treasury assets and leverage the potential of blockchain-based digital currencies. The Company remains committed to prudent financial management while exploring innovative avenues to drive stockholder value.
“Windtree’s strategy to integrate BNB into its treasury reflects a forward-thinking approach to value creation,” said Patrick Horsman, CFA, Director of Build and Build Corp. “The ELOC provides the flexibility and scale needed to execute on this digital asset treasury vision.”
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Windtree Therapeutics, Inc.
Windtree Therapeutics, Inc. is a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for which the Company is actively seeking long-term development partners.
About Build and Build Corp
Build and Build Corp is a dynamic company established by Patrick Horsman, Joshua Kruger, and Johnathan Pasch, who together bring over 43 years of expertise in hedge funds and digital asset management. The company is backed by prominent investors, including Discovery Capital, Off The Chain Capital, Kraken, Galaxy Digital, Gaia Digital Asset, and Silvermine, supporting its mission to deliver innovative solutions in the financial and digital asset sectors.
Forward-Looking Statements
The Company may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are based on information available to the Company as of the date of this press release and are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from the Company’s current expectations. Examples of such risks and uncertainties include, among other things: risks related to obtaining stockholder approval for the Build and Build Corp transaction and satisfying the other conditions necessary to consummate the transaction and related transactions, including the Company’s abilities to meet the conditions required to make sales pursuant to the ELOC; the Company’s ability to manage costs and execute on its operational and budget plans; risks related to the regulatory environment for cryptocurrency transactions; and the Company’s ability to develop and maintain its BNB Crypto Treasury Strategy. These and other risks are described in the Company’s periodic reports, including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, filed with or furnished to the Securities and Exchange Commission and available at www.sec.gov. Any forward-looking statements that the Company makes in this press release speak only as of the date of this press release. The Company assumes no obligation to update forward-looking statements whether as a result of new information, future events, or otherwise, after the date of this press release.
Contact Information:
Eric Curtis
ecurtis@windtreetx.com
FAQ
How much funding has Windtree Therapeutics (WINT) secured for its BNB cryptocurrency strategy?
What percentage of the new funding will WINT use to purchase BNB cryptocurrency?
What conditions must be met for Windtree to access the $500 million ELOC?
Who is providing the $20 million stock purchase agreement to Windtree Therapeutics?
What is the purpose of Windtree's BNB cryptocurrency treasury strategy?
